Cyprenorphine

Source: Wikipedia, the free encyclopedia.
Cyprenorphine
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • 6,7,8,14-tetrahydro- N-(Cyclopropylmethyl)- 7α-(1-hydroxy-1-methylethyl)- 6,14-endo-ethenonororipavine
JSmol)
  • CC(C)(O)[C@H]7C[C@]53/C=C/[C@]7(OC)[C@@H]1Oc6c2c(C[C@H]5N(CC[C@@]123)CC4CC4)ccc6O
  • InChI=1S/C26H33NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-9,15,18-19,22,28-29H,4-5,10-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1 checkY
  • Key:VSKIOMHXEUHYSI-KNLIIKEYSA-N checkY
  (verify)

Cyprenorphine (M285), N-cyclo-propylmethyl-6,14-endoetheno-7α-(1-hydroxy-1-methylethyl)-6,7,8,14-tetrahydronororipavine, is an

opioid addiction, and diprenorphine, which is used as an antidote to reverse the effects of other opioids. It is roughly 35 times as strong as nalorphine.[1]

Cyprenorphine is a powerful antagonist of opioid receptors[2] and a highly potent specific antagonist.[3] It blocks the binding of morphine and etorphine to these receptors.[3]

Cyprenorphine has mixed

hallucinogenic effects which limit its potential use as an analgesic.[4][5]

Cyprenorphine also has been shown to suppress the intake of sweet solution[2] but doesn't suppress the increase in food consumption that is produced by the alpha-2-adrenoceptor antagonist idazoxan. Idazoxan may lead to the release of endogenous opioid peptides and increase food intake, this effect is attenuated by (-)-naloxone but not by the mu/delta-antagonist cyprenorphine.[6]

Medical uses

Cyprenorphine increases locomotor activity.

intravenously in the femoral vein of the immobile animal.[8] Unlike other antagonists, used to reverse the effects of etorphine, the dose of cyprenorphine administered depends on the initial dose of etorphine instead of the weight of the animal. The recommended dose of cyprenorphine is three times that of the initial etorphine administered. Although the effects of cyprenorphine typically take from 40 to 60 seconds to kick in, it has been observed to take up to 3 hours in white rhinoceroses.[3]

Adverse effects

Cyprenorphine induces depression over an hour in rats.

psychotomimetic actions in humans[9] and dysphoria when used as a post-operative analgesic in patients.[10] Because of these side effects, it is seldom used in humans, with diprenorphine
preferred instead.

Mechanism of action

Although it is still unclear how cyprenorphine antagonizes the effects of etorphine, it has been suggested that its greater

isoform of Cyprenorphine is an antagonist of the delta, mu and kappa opioid receptors. Its elimination rate constants (Ke) at these receptors are 0.68, 0.076 and 0.79 nM respectively.[12]

References